Lynn McGregor
![Lynn McGregor Lynn McGregor](https://covalent-drug-discovery.com/wp-content/uploads/sites/907/2024/07/47964-Novartis-Lynn-McGregor-150x150.png)
Company: Novartis AG
Job title: Senior Principal Scientist
Seminars:
Roundtable Discussion: Fueling the Covalency Renaissance by Strategizing the Chemistry Toolbox to Target Residues Beyond Cysteine with Orthogonal Reactivity 4:30 pm
Which amino acids are seen as the next frontier in covalent drug discovery? What is the mass spectrometry or alternative screening toolbox for other amino acids? How can we build drug-like warheads that hit other sidechains? Should we be screening these more promiscuous warheads? What are the different methods to validate non-cysteine covalency in simplified…Read more
day: Conference Day One
Covalency Offers Unique Opportunities for Difficult Targets 9:00 am
Covalency provides opportunities for difficult drug targets Screening identifies a starting point for a TF target Proteomics is an essential tool for covalency focused efforts Read more
day: Conference Day One